Pharmaceutical Product Quality Testing (PPQT) Market and Demand Generation Consultant

Pharmaceutical Product Quality Testing (PPQT) Market and Demand Generation Consultancy

The U.S. Pharmacopeial Convention (USP) is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, dietary supplements, and food ingredients. Through our resources, standards, advocacy, and education, USP helps increase the availability of quality medicines, supplements, and foods for billions of people worldwide. Our programs have reached more than 90 countries across Africa, Asia, and South America, strengthening global supply chains and pharmaceutical ecosystems that enable a resilient supply of high-quality medical products. 

USP’s Pharmaceutical Product Quality Testing (PPQT) program is a voluntary post-marketing testing program for generic medicines, enabling purchasers and suppliers to demonstrate their commitment to quality medicines in the last mile. The program utilizes validated quality testing methods, either those found in USP’s public quality standards or those accepted by the FDA.

The Supply Chain Resilience department at USP is seeking a consultant to develop marketing and demand generation resources for the PPQT program and lead the organization and delivery of a roundtable on marketplace drug quality concerns for purchasers, including GPOs, Payors, & Health Systems.

Roles and Responsibilities

1. Collaborate with USP to develop a plan for the engagement of key stakeholders who may be concerned about drug quality in the last mile including purchasers, payors, and health systems.
2. Identify a subset of key stakeholders who have drug quality factors already part of their evaluation considerations for formulary and procurement decisions, and develop marketing and demand generation resources targeted at those stakeholders.
3. Review and comment on the PPQT risk-based drug quality sampling and testing approach which intends to identify and prioritize products for sampling and testing in the U.S. market based on predefined quality risks, thereby reducing exposure to poor quality medicines, ensuring public trust for procurers and health systems, and safeguarding patient safety, comment on the draft Quality Watch List, and review and comment on the PPQT workflow for purchasers.
4. Draft agenda for a roundtable workshop on drug quality in the last mile, and finalize the agenda based on inputs and review from USP.
5. Develop the overall roundtable program, including workshop objectives and expected outcomes, topics including review of the PPQT workflow and related tools, identify speakers, develop run-of-show, and serve as facilitator for the workshop.
6. Lead the facilitation of the roundtable, documentation of main messages, and development of final meeting reports and next steps.

Deliverables

1. Key stakeholders’ engagement plan, marketing, and demand generation outreach plan
2. Workshop agenda and preparatory documents
3. Final roundtable workshop reports
4. Report on PPQT workflow and Quality Watch List and their application
5. Recommendations on the next steps for PPQT demand generation outreach to purchasers and payors.

Period of engagement –

• Two months, preferably from August 4^th to October 3^rd, 2025.

Consultant qualifications –

• Advanced degrees in medicine, pharmacy, health sciences, or law.
• Expert in medical products supply chain.
• Deep understanding of the U.S. health system
• Extensive hands-on experience in managing health systems at an executive level.